Cytocast revolutionizes the fields of drug discovery and personalized treatment through a comprehensive cell simulator.
Cytocast has raised $1.8M in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2023.
Cytocast's investors include Bonitas Ventures, FastVentures, Creative Accelerator, Futurmed, Zoiros Ventures.
Cytocast is headquartered in Budapest, Hungary.
Cytocast revolutionizes the fields of drug discovery and personalized treatment through a comprehensive cell simulator.
Cytocast is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cytocast — Funding & Investors." VCBacked, May 15, 2023, https://www.vcbacked.co/company/cytocast. Accessed July 19, 2026.
VCBacked. (2023). Cytocast — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cytocast
{{cite web |title=Cytocast — Funding & Investors |url=https://www.vcbacked.co/company/cytocast |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated